The interrelationship and accumulation of cardiometabolic risk factors amongst young adults in the United Arab Emirates: The UAE Healthy Future Study.

Cardiometabolic risk factors Cardiovascular disease Central obesity Dysglycemia Dyslipidemia Hypertension Metabolic Syndrome Obesity

Journal

Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958

Informations de publication

Date de publication:
27 Nov 2021
Historique:
received: 03 08 2021
accepted: 12 11 2021
entrez: 28 11 2021
pubmed: 29 11 2021
medline: 29 11 2021
Statut: epublish

Résumé

Similar to other non-communicable diseases (NCDs), people who develop cardiovascular disease (CVD) typically have more than one risk factor. The clustering of cardiovascular risk factors begins in youth, early adulthood, and middle age. The presence of multiple risk factors simultaneously has been shown to increase the risk for atherosclerosis development in young and middle-aged adults and risk of CVD in middle age. This study aimed to address the interrelationship of CVD risk factors and their accumulation in a large sample of young adults in the United Arab Emirates (UAE). Baseline data was drawn from the UAE Healthy Future Study (UAEHFS), a volunteer-based multicenter study that recruits Emirati nationals. Data of participants aged 18 to 40 years was used for cross-sectional analysis. Demographic and health information was collected through self-reported questionnaires. Anthropometric data and blood pressure were measured, and blood samples were collected. A total of 5126 participants were included in the analysis. Comorbidity analyses showed that dyslipidemia and obesity co-existed with other cardiometabolic risk factors (CRFs) more than 70% and 50% of the time, respectively. Multivariate logistic regression analysis of the risk factors with age and gender showed that all risk factors were highly associated with each other. The strongest relationship was found with obesity; it was associated with four-fold increase in the odds of having central obesity [adjusted OR 4.70 (95% CI (4.04-5.46)], and almost three-fold increase odds of having abnormal glycemic status [AOR 2.98 (95% (CI 2.49-3.55))], hypertension (AOR 3.03 (95% CI (2.61-3.52))] and dyslipidemia [AOR 2.71 (95% CI (2.32-3.15)]. Forty percent of the population accumulated more than 2 risk factors, and the burden increased with age. In this young population, cardiometabolic risk factors are highly prevalent and are associated with each other, therefore creating a heavy burden of risk factors. This forecasts an increase in the burden of CVD in the UAE. The robust longitudinal design of the UAEHFS will enable researchers to understand how risk factors cluster before disease develops. This knowledge will offer a novel approach to design group-specific preventive measures for CVD development.

Identifiants

pubmed: 34838113
doi: 10.1186/s13098-021-00758-w
pii: 10.1186/s13098-021-00758-w
pmc: PMC8627022
doi:

Types de publication

Journal Article

Langues

eng

Pagination

140

Informations de copyright

© 2021. The Author(s).

Références

Arch Intern Med. 1999 May 24;159(10):1104-9
pubmed: 10335688
Cardiovasc Diabetol. 2009 Apr 16;8:21
pubmed: 19371412
Am J Hypertens. 2007 Jun;20(6):599-607
pubmed: 17531915
Circulation. 2007 Feb 27;115(8):1004-11
pubmed: 17283263
J Cardiovasc Dev Dis. 2019 Apr 27;6(2):
pubmed: 31035613
Heart. 2008 Oct;94(10):1331-2
pubmed: 18701534
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Diabetes Care. 2003 Mar;26(3):805-9
pubmed: 12610041
Arch Intern Med. 2007 May 28;167(10):1068-74
pubmed: 17533210
Circulation. 2009 Jan 27;119(3):382-9
pubmed: 19139385
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Eur Heart J. 2016 Jul 01;37(25):1944-58
pubmed: 27122601
Diabetes Care. 2009 Jul;32(7):1327-34
pubmed: 19502545
Age (Dordr). 2016 Feb;38(1):23
pubmed: 26846415
Diabetes. 2010 May;59(5):1153-60
pubmed: 20185808
Pathology. 2019 Feb;51(2):131-141
pubmed: 30522787
Clin Chem. 2011 Aug;57(8):1178-87
pubmed: 21700954
Endocrinol Diabetes Metab. 2019 Jun 28;2(4):e00081
pubmed: 31592445
Am J Public Health. 2012 May;102(5):909-14
pubmed: 21940918
Diabetes Care. 2010 Jan;33 Suppl 1:S62-9
pubmed: 20042775
J Am Heart Assoc. 2015 Apr 24;4(4):
pubmed: 25911605
BMC Public Health. 2018 Jan 5;18(1):101
pubmed: 29304844
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Prev Med. 2003 Oct;37(4):363-7
pubmed: 14507494

Auteurs

Fatima Mezhal (F)

Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, UAE. Fam6@nyu.edu.

Abderrahim Oulhaj (A)

Department of Epidemiology and Public Health, College of Medicine and Health Sciences, Khalifa University of Sciences and Technology, Abu Dhabi, UAE.

Abdishakur Abdulle (A)

Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, UAE.

Abdulla AlJunaibi (A)

Department of Pediatrics, Zayed Military Hospital, Abu Dhabi, UAE.

Abdulla Alnaeemi (A)

Department of Cardiology, Zayed Military Hospital, Abu Dhabi, UAE.

Amar Ahmad (A)

Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, UAE.

Andrea Leinberger-Jabari (A)

Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, UAE.

Ayesha S Al Dhaheri (AS)

Department of Nutrition and Health, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE.

E Murat Tuzcu (EM)

Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.

Eiman AlZaabi (E)

Department of Pathology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.

Fatma Al-Maskari (F)

Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE.
Zayed Center for Health Sciences, United Arab Emirates University, Al-Ain, UAE.

Fatme Alanouti (F)

College of Natural and Health Sciences, Zayed University, Abu Dhabi, UAE.

Fayza Alameri (F)

Zayed Military Hospital, Abu Dhabi, UAE.

Habiba Alsafar (H)

Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, UAE.
Department of Genetics and Molecular Biology, Khalifa University of Science and Technology, Abu Dhabi, UAE.
Department of Biomedical Engineering, Khalifa University of Science and Technology, Abu Dhabi, UAE.

Hamad Alblooshi (H)

Abu Dhabi Blood Bank Services, SEHA, Al-Ain, Abu Dhabi, UAE.

Juma Alkaabi (J)

Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE.

Laila Abdel Wareth (LA)

Pathology and Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.

Mai Aljaber (M)

Healthpoint Hospital, Abu Dhabi, UAE.

Marina Kazim (M)

Abu Dhabi Blood Bank Services, SEHA, Al-Ain, Abu Dhabi, UAE.

Micheal Weitzman (M)

Department of Environmental Medicine, New York University of Medicine, New York, USA.

Mohammad Al-Houqani (M)

Department of Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE.

Mohammad Hag Ali (MH)

Department of Health Science, Higher Colleges of Technology, Abu Dhabi, UAE.

Naima Oumeziane (N)

Abu Dhabi Blood Bank Services, SEHA, Al-Ain, Abu Dhabi, UAE.

Omar El-Shahawy (O)

Department of Population Health, New York University School of Medicine, New York, USA.

Rami H Al-Rifai (RH)

Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE.

Scott Scherman (S)

Department of Population Health, New York University School of Medicine, New York, USA.

Syed M Shah (SM)

Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE.

Tom Loney (T)

College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.

Wael Almahmeed (W)

Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.

Youssef Idaghdour (Y)

Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, UAE.

Luai A Ahmed (LA)

Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, UAE.
Zayed Center for Health Sciences, United Arab Emirates University, Al-Ain, UAE.

Raghib Ali (R)

Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, UAE.
MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

Classifications MeSH